Cargando…
Immune checkpoint inhibitor-associated new-onset primary adrenal insufficiency: a retrospective analysis using the FAERS
BACKGROUND: Our study aimed to investigate the prevalence and demographic characteristics of immune checkpoint inhibitor-associated primary adrenal insufficiency (ICI-PAI) and to explore the risk factors of its clinical outcome using data from the US FDA Adverse Event Reporting System (FAERS). METHO...
Autores principales: | Lu, D., Yao, J., Yuan, G., Gao, Y., Zhang, J., Guo, X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525402/ https://www.ncbi.nlm.nih.gov/pubmed/35870109 http://dx.doi.org/10.1007/s40618-022-01845-z |
Ejemplares similares
-
Adrenal Insufficiency Masquerading as Primary Hypothyroidism Following Immune Checkpoint Inhibitors Treatment
por: Salim, Michael, et al.
Publicado: (2021) -
PSAT042 Adrenal Insufficiency Associated to Immune Checkpoint Inhibitors
por: Barreto, Brigida Colon, et al.
Publicado: (2022) -
Autoantibodies involved in primary and secondary adrenal insufficiency following treatment with immune checkpoint inhibitors
por: Helderman, N.C., et al.
Publicado: (2023) -
Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature
por: Salinas, Carlos, et al.
Publicado: (2020) -
MON-181 Clinical Features of Immune Checkpoint Inhibitor-Related Adrenal Insufficiency: A Retrospective Analysis
por: Zhou, Qinwen Jenny, et al.
Publicado: (2020)